Neurosurgeons and researchers at Cedars-Sinai Medical Center in Los Angeles are adapting an ultraviolet camera to possibly bring the technology into the operating room.

PET imaging detected amyloid-beta (AB) deposition 15 years prior to expected onset of symptoms among persons with genetic mutations, predisposing them to autosomal-dominant Alzheimers disease, according to a study published July 12 in the New England Journal of Medicine. The researchers also reported concentrations of AB in cerebrospinal fluid (CSF) 25 years before symptom onset and increased tau protein in CSF 15 years prior to symptoms.

Among patients with mild or no cognitive impairment, PET imaging using florbetapir, which binds to amyloid plaques in the brain, has been shown to detect early evidence of Alzheimers disease (AD) that may predict future decline, according to findings published online July 11 in Neurology.

At Health Imaging, we like to think of July and August as a bit of downtimethe breather before the run-up to RSNA. That characterization may represent fantasy more than reality.

A new ultrasound approach which provides information on microvessel morphology could eventually lead to a quick, inexpensive, bedside method of identifying cancers when tumors are less than a centimeter in size, according to preclinical research published July 6 online in Radiology.

The FDA has approved a stem cell therapy that will work to repair damage caused by heart attacks, according to a release from the California Institute for Regenerative Medicine. The approval will be the first-in-human use for the therapy in clinical trials.

As the number and type of breast imaging modalities have multiplied and research has demonstrated their effectiveness, it may be time for womens imaging practices to consider the role of new technologies in breast cancer screening and detection.

The National Institutes of Health (NIH) has awarded SignaBlok a grant to develop multifunctional nanoformulations for diagnostic imaging of atherosclerosis.